Page 1 | Search Results | Diabetes | American Diabetes Association

1-20 of 150

Sort by

Sort Order Select

Journal Articles

Dissecting the Neurovascular Unit in Human Diabetic Retinal Disease

Thomas W. Gardner, Toke Bek

Diabetes 2024;73(11):1791–1792

https://doi.org/10.2337/dbi24-0036

Published: 21 October 2024

View article titled, Dissecting the Neurovascular Unit in Human Diabetic Retinal Disease

Meeting Abstracts

1352-P: Ethnic Disparities in Diabetic Complications in the U.S.

YILIN YOSHIDA, VIVIAN FONSECA, YUANHAO ZU

Diabetes 2023;72(Supplement_1):1352-P

https://doi.org/10.2337/db23-1352-P

Published: 20 June 2023

View article titled, 1352-P: Ethnic Disparities in Diabetic Complications in the U.S.

Meeting Abstracts

256-OR: Hypoglycemia Effect on Relationship of Renal and/or Retinal Disease with CVD and Vice Versa

ELKE R. FAHRMANN, HENRY DRISCOLL

Diabetes 2023;72(Supplement_1):256-OR

https://doi.org/10.2337/db23-256-OR

Published: 20 June 2023

View article titled, 256-OR: Hypoglycemia Effect on Relationship of Renal and/or Retinal Disease with CVD and Vice Versa

Meeting Abstracts

269-OR: Empagliflozin on the Risk of Retinopathy in Patients with Type 2 Diabetes—Results from the EMPRISE Study

HELEN TESFAYE, PHYO T. HTOO, JULIE M. PAIK, HEIDI ZAKOUL, NIKLAS SCHMEDT, ANOUK DERUAZ-LUYET, LISETTE KOENEMAN, DEBORAH J. WEXLER, ELISABETTA PATORNO

Diabetes 2023;72(Supplement_1):269-OR

https://doi.org/10.2337/db23-269-OR

Published: 20 June 2023

View article titled, 269-OR: Empagliflozin on the Risk of Retinopathy in Patients with Type 2 Diabetes—Results from the EMPRISE Study

Meeting Abstracts

324-OR: VEGF Is a Contributing Factor for the Reduction of Retinal Function in Diabetic Retinopathy and Hypoxic Retinal Disorders

YUN LE, MEILI ZHU

Diabetes 2023;72(Supplement_1):324-OR

https://doi.org/10.2337/db23-324-OR

Published: 20 June 2023

View article titled, 324-OR: VEGF Is a Contributing Factor for the Reduction of Retinal Function in Diabetic Retinopathy and Hypoxic Retinal Disorders

Meeting Abstracts

1360-P: Health Disparities in Clinical Research among Those Living with Diabetes-Related Retinopathy

LILLIAN H. COOPER, LEXIE AINLEY, HENRY STEVENS, KEVIN QUINN, BLAKE A. COOPER

Diabetes 2023;72(Supplement_1):1360-P

https://doi.org/10.2337/db23-1360-P

Published: 20 June 2023

View article titled, 1360-P: Health Disparities in Clinical Research among Those Living with Diabetes-Related Retinopathy

Meeting Abstracts

1005-P: Developing a Machine-Learning–Based Prediction Model for Diabetes Duration Using Information from Electronic Health Records

DAWEI GUAN, PIAOPIAO LI, VIVIAN FONSECA, LIZHENG SHI, MOHAMMED K. ALI, JITHIN SAM VARGHESE, RODRIGO M. CARRILLO-LARCO, MASOUD ROUHIZADEH, ALMUT G. WINTERSTEIN, TIANZE JIAO, HUI SHAO

Diabetes 2023;72(Supplement_1):1005-P

https://doi.org/10.2337/db23-1005-P

Published: 20 June 2023

View article titled, 1005-P: Developing a Machine-Learning–Based Prediction Model for Diabetes Duration Using Information from Electronic Health Records

Meeting Abstracts

499-P: Leveraging the Technological Advances of Virtual Reality (VR) to Foster Engaging and Interactive Learning, Ultimately Impacting Patient Quality of Care

RUSSIE ALLEN, LAUREN K. WELCH

Diabetes 2023;72(Supplement_1):499-P

https://doi.org/10.2337/db23-499-P

Published: 20 June 2023

View article titled, 499-P: Leveraging the Technological Advances of Virtual Reality (VR) to Foster Engaging and Interactive Learning, Ultimately Impacting Patient Quality of Care

Meeting Abstracts

501-P: Differences in Disease Severity and Treatment for Diabetes-Related Retinopathy between Type 1 and 2 Diabetes Mellitus

JAMES M. BREEN, AMELIA COOPER, HENRY STEVENS, BLAKE A. COOPER

Diabetes 2023;72(Supplement_1):501-P

https://doi.org/10.2337/db23-501-P

Published: 20 June 2023

View article titled, 501-P: Differences in Disease Severity and Treatment for Diabetes-Related Retinopathy between Type 1 and 2 Diabetes Mellitus

Meeting Abstracts

500-P: Causal Effect of SGLT2 Inhibition on Diabetes-Related Retinopathy (DR) and Macular Edema (DME)

HENRY STEVENS, JAMES M. BREEN, BLAKE A. COOPER

Diabetes 2023;72(Supplement_1):500-P

https://doi.org/10.2337/db23-500-P

Published: 20 June 2023

View article titled, 500-P: Causal Effect of SGLT2 Inhibition on Diabetes-Related Retinopathy (DR) and Macular Edema (DME)

Meeting Abstracts

399-P: Associations among Biomarkers of Inflammation, Tubular Injury, and Lipid Metabolism with Gestational Diabetes Mellitus (GDM) Status, Microalbuminuria, and Retinopathy in the MARIGOLD Study

HONGYAN LIU, VIKAS S. SRIDHAR, LEIF ERIK LOVBLOM, DENICE FEIG, ELAINE HERER, ALEX KISS, LORRAINE LIPSCOMBE, PAUL M. YIP, DAVID CHERNEY, BAIJU R. SHAH

Diabetes 2022;71(Supplement_1):399-P

https://doi.org/10.2337/db22-399-P

Published: 01 June 2022

View article titled, 399-P: Associations among Biomarkers of Inflammation, Tubular Injury, and Lipid Metabolism with Gestational Diabetes Mellitus (GDM) Status, Microalbuminuria, and Retinopathy in the MARIGOLD Study

Meeting Abstracts

1485-PUB: Assessing Correlates of Microvascular Complications among Patients with Diabetes Mellitus

KENNETH IZUORA, AMALIE ALVER, ARPITA BASU, KAVITA BATRA, SHELLEY J. WILLIAMS, JEFFREY L. EBERSOLE

Diabetes 2022;71(Supplement_1):1485-PUB

https://doi.org/10.2337/db22-1485-PUB

Published: 01 June 2022

View article titled, 1485-PUB: Assessing Correlates of Microvascular Complications among Patients with Diabetes Mellitus

Meeting Abstracts

48-OR: Barriers to Follow-Up Specialized Eye Care following Retinopathy Identification with Traditional vs. Autonomous Artificial Intelligence (AI) Camera

MATTHEW WAHL, RABIA KIANI, JULIE NEUBERGER, BONNIE WILSON, MARY ELIZABETH HARTNETT, SIMON FISHER

Diabetes 2022;71(Supplement_1):48-OR

https://doi.org/10.2337/db22-48-OR

Published: 01 June 2022

View article titled, 48-OR: Barriers to Follow-Up Specialized Eye Care following Retinopathy Identification with Traditional vs. Autonomous Artificial Intelligence (AI) Camera

Meeting Abstracts

94-OR: CGM Metrics, HbA1c, and Retinopathy Are Differentially Associated by Disease Duration in Long-Duration Type 1 Diabetes

MARC GREGORY YU, TAHANI BOUMENNA, JOHN GAUTHIER, REGINA THAM, WARD FICKWEILER, JENNIFER SUN, HETAL SHAH, GEORGE L. KING

Diabetes 2022;71(Supplement_1):94-OR

https://doi.org/10.2337/db22-94-OR

Published: 01 June 2022

View article titled, 94-OR: CGM Metrics, HbA1c, and Retinopathy Are Differentially Associated by Disease Duration in Long-Duration Type 1 Diabetes

Meeting Abstracts

472-P: Sex Differences in the Effect of High Serum Uric Acid on the Incidence of Vision-Threatening Retinopathy in Those with Type 2 Diabetes

MASAHIKO YAMAMOTO, KAZUYA FUJIHARA, HAJIME ISHIGURO, YUTA YAGUCHI, MASAHIRO ISHIZAWA, MAYUKO H. YAMADA, TAEKO OSAWA, MASARU KITAZAWA, MASANORI KANEKO, YASUHIRO MATSUBAYASHI, MIDORI IWANAGA, TAKAHO YAMADA, SATORU KODAMA, HIROHITO SONE

Diabetes 2022;71(Supplement_1):472-P

https://doi.org/10.2337/db22-472-P

Published: 01 June 2022

View article titled, 472-P: Sex Differences in the Effect of High Serum Uric Acid on the Incidence of Vision-Threatening Retinopathy in Those with Type 2 Diabetes

Journal Articles

Systematic Heritability and Heritability Enrichment Analysis for Diabetes Complications in UK Biobank and ACCORD Studies

Juhyun Kim, Aubrey Jensen, Seyoon Ko, Sridharan Raghavan, Lawrence S. Phillips, Adriana Hung, Yan Sun, Hua Zhou, Peter Reaven, Jin J. Zhou

Diabetes 2022;71(5):1137–1148

https://doi.org/10.2337/db21-0839

Published: 08 February 2022

View article titled, Systematic Heritability and Heritability Enrichment Analysis for Diabetes Complications in UK Biobank and ACCORD Studies

Journal Articles

Metabolic and Metabo-Clinical Signatures of Type 2 Diabetes, Obesity, Retinopathy, and Dyslipidemia

Noha A. Yousri, Karsten Suhre, Esraa Yassin, Alya Al-Shakaki, Amal Robay, Maha Elshafei, Omar Chidiac, Steven C. Hunt, Ronald G. Crystal, Khalid A. Fakhro

Diabetes 2022;71(2):184–205

https://doi.org/10.2337/db21-0490

Published: 03 November 2021

View article titled, Metabolic and Metabo-Clinical Signatures of Type 2 Diabetes, Obesity, Retinopathy, and Dyslipidemia

Meeting Abstracts

432-P: Sodium Intake and Incidence of Diabetes Retinopathy in Elderly Patients with Type 2 Diabetes: Analysis of Data from the Japanese Elderly Diabetes Intervention Study (J-EDIT)

CHIKA HORIKAWA, REI AIDA, SHIRO TANAKA, CHIEMI KAMADA, SACHIKO TANAKA, YUKIO YOSHIMURA, REMI KODERA, KAZUYA FUJIHARA, RYO KAWASAKI, TATSUMI MORIYA, HIROHITO SONE, ATSUSHI ARAKI

Diabetes 2021;70(Supplement_1):432-P

https://doi.org/10.2337/db21-432-P

Published: 01 June 2021

View article titled, 432-P: Sodium Intake and Incidence of Diabetes Retinopathy in Elderly Patients with Type 2 Diabetes: Analysis of Data from the Japanese Elderly Diabetes Intervention Study (J-EDIT)

Meeting Abstracts

92-OR: Increased Disease Detection, Yet Treatment Barriers Identified, with Point-of-Care Retinopathy Screening

MATTHEW WAHL, JULIE NEUBERGER, MICHELLE L. LITCHMAN, GLADYS S. ADJEI-POKU, ANGELA FAGERLIN, MARY ELIZABETH HARTNETT, SIMON FISHER

Diabetes 2021;70(Supplement_1):92-OR

https://doi.org/10.2337/db21-92-OR

Published: 01 June 2021

View article titled, 92-OR: Increased Disease Detection, Yet Treatment Barriers Identified, with Point-of-Care Retinopathy Screening

Journal Articles

CaM Kinase II-δ Is Required for Diabetic Hyperglycemia and Retinopathy but Not Nephropathy

Diabetes 2021;70(2):616–626

https://doi.org/10.2337/db19-0659

Published: 25 November 2020

View article titled, CaM Kinase II-δ Is Required for Diabetic Hyperglycemia and Retinopathy but Not Nephropathy

NARROW

Dissecting the Neurovascular Unit in Human Diabetic Retinal Disease

1352-P: Ethnic Disparities in Diabetic Complications in the U.S.

256-OR: Hypoglycemia Effect on Relationship of Renal and/or Retinal Disease with CVD and Vice Versa

269-OR: Empagliflozin on the Risk of Retinopathy in Patients with Type 2 Diabetes—Results from the EMPRISE Study

324-OR: VEGF Is a Contributing Factor for the Reduction of Retinal Function in Diabetic Retinopathy and Hypoxic Retinal Disorders

1360-P: Health Disparities in Clinical Research among Those Living with Diabetes-Related Retinopathy

1005-P: Developing a Machine-Learning–Based Prediction Model for Diabetes Duration Using Information from Electronic Health Records

499-P: Leveraging the Technological Advances of Virtual Reality (VR) to Foster Engaging and Interactive Learning, Ultimately Impacting Patient Quality of Care

501-P: Differences in Disease Severity and Treatment for Diabetes-Related Retinopathy between Type 1 and 2 Diabetes Mellitus

500-P: Causal Effect of SGLT2 Inhibition on Diabetes-Related Retinopathy (DR) and Macular Edema (DME)

399-P: Associations among Biomarkers of Inflammation, Tubular Injury, and Lipid Metabolism with Gestational Diabetes Mellitus (GDM) Status, Microalbuminuria, and Retinopathy in the MARIGOLD Study

1485-PUB: Assessing Correlates of Microvascular Complications among Patients with Diabetes Mellitus

48-OR: Barriers to Follow-Up Specialized Eye Care following Retinopathy Identification with Traditional vs. Autonomous Artificial Intelligence (AI) Camera

94-OR: CGM Metrics, HbA1c, and Retinopathy Are Differentially Associated by Disease Duration in Long-Duration Type 1 Diabetes

472-P: Sex Differences in the Effect of High Serum Uric Acid on the Incidence of Vision-Threatening Retinopathy in Those with Type 2 Diabetes

Systematic Heritability and Heritability Enrichment Analysis for Diabetes Complications in UK Biobank and ACCORD Studies

Metabolic and Metabo-Clinical Signatures of Type 2 Diabetes, Obesity, Retinopathy, and Dyslipidemia

432-P: Sodium Intake and Incidence of Diabetes Retinopathy in Elderly Patients with Type 2 Diabetes: Analysis of Data from the Japanese Elderly Diabetes Intervention Study (J-EDIT)

92-OR: Increased Disease Detection, Yet Treatment Barriers Identified, with Point-of-Care Retinopathy Screening

CaM Kinase II-δ Is Required for Diabetic Hyperglycemia and Retinopathy but Not Nephropathy

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only